| abstract |
The present invention is directed to compounds having the formula (I): n n nuseful in treating inflammatory and immune diseases, in which K is O or S; Q is —C(═O)— or optionally substituted C 1-4 alkylene; Ar is optionally-substituted aryl or heteroaryl; J 1 , J 2 , J 3 , and Y are selected so that ring A is a five-to-six membered optionally-substituted cycloalkenyl or heterocyclo ring having 0 to 2 nitrogen heteroatoms; Z is N or C(R 9 ); and R 1 , R 2 , R 3 and R 9 are as defined in the specification. |